The FTO opportunity fell out of the sky and landed on a random small biotech company somewhere on planet Earth. What is the a priori chance that the small biotech company has the mananagement and financial resources to take full advantage of this opportunity?
In an unrelated event, cardioprotection was discovered soon afterwards by the same small biotech company, which now has two massive opportunities. What is the a priori chance that its Board members will have identical views or even differing but compatible views on what to do next?
Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett, page-64
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.76 |
Change
-0.055(3.03%) |
Mkt cap ! $306.7M | |||
| Open | High | Low | Value | Volume |
| $1.81 | $1.82 | $1.76 | $129.4K | 72.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1583 | $1.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.77 | 1145 | 2 |
View Market Depth
| Last trade - 15.55pm 27/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |